Inflammation and survival pathways: chronic lymphocytic leukemia as a model system

Lisa S Chen1, Kumudha Balakrishnan, Varsha Gandhi

  • 1Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4095, USA.

Biochemical Pharmacology
|August 11, 2010
PubMed
Summary

Inflammation increases cell survival via anti-apoptotic Bcl-2 proteins and Pim kinases. These pathways, crucial in chronic lymphocytic leukemia (CLL), offer survival advantages and are targeted by new cancer drugs.